Eli Lilly & Co. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Eli Lilly & Co. (LLY) shares rose 1.97% to $1,185.87 on Thursday, outperforming competitors like Johnson & Johnson, Pfizer, and AbbVie despite a broader market decline where the S&P 500 fell 1.21%. The stock closed 5.09% below its 52-week high of $1,249.45. Trading volume was lower than the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Eli Lilly & Co. (LLY) rose 1.97% to $1,185.87 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.21% to 7,408.30 and Dow Jones Industrial Average falling 0.97% to 51,711.65.
Eli Lilly & Co. closed 5.09% short of its 52-week high of $1,249.45, which the company reached on July 7th.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 1.42% to $259.27, Pfizer Inc. (PFE) rose 0.77% to $25.01, and AbbVie Inc. (ABBV) rose 1.43% to $256.92.
Trading volume (1.9 M) remained 1.2 million below its 50-day average volume of 3.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-23-26 1632ET